bioMérieux
A global leader in in vitro diagnostics for clinical and industrial applications.
BIM | PA
Overview
Corporate Details
- ISIN(s):
- FR0013280286 (+13 more)
- LEI:
- 549300AK8Y0LBIQ4T071
- Country:
- France
- Address:
- 376 CHE DE L'ORME, 69280 MARCY-L'ETOILE
- Website:
- https://www.biomerieux.com/
- Sector:
- Manufacturing
Description
bioMérieux is a global leader in the field of in vitro diagnostics, providing solutions that determine the source of disease and contamination. The company develops and manufactures diagnostic systems, reagents, and software for both clinical and industrial applications. In the clinical sector, its products are used for diagnosing infectious diseases, managing sepsis, combating antimicrobial resistance, and supporting cancer screening and cardiovascular emergencies. For industrial markets, bioMérieux offers microbiological control solutions to ensure the safety and quality of agri-food, pharmaceutical, and cosmetic products. These technologies provide rapid and reliable data to help healthcare professionals and industrial quality control managers make critical decisions that improve patient outcomes and ensure consumer safety.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2024-05-06 17:18 |
Avril 2024 - Déclaration sur le nombre d'actions composant le capital social et…
|
French | PDF • 106.1 KB | ||
| 2024-04-09 07:15 |
bioMérieux presents its new 5-year strategic plan and its targets for profitabl…
|
English | PDF • 206.0 KB | ||
| 2024-04-09 07:15 |
bioMérieux présente son nouveau plan stratégique à 5 ans et son objectif de cro…
|
French | PDF • 192.1 KB | ||
| 2024-04-09 07:01 |
bioMérieux – First-Quarter 2024 Business Review
|
English | PDF • 263.9 KB | ||
| 2024-04-09 07:01 |
bioMérieux – Information financière du 1er trimestre 2024
|
French | PDF • 223.7 KB | ||
| 2024-04-05 08:59 |
Mars 2024 - Déclaration sur le nombre d'actions composant le capital social et …
|
French | PDF • 106.1 KB | ||
| 2024-04-05 07:01 |
bioMérieux and Mérieux NutriSciences partner with key food industry players to …
|
English | PDF • 294.2 KB | ||
| 2024-04-05 07:01 |
bioMérieux et Mérieux NutriSciences s'associent à des acteurs clés de l'industr…
|
French | PDF • 295.1 KB | ||
| 2024-03-28 10:52 |
Release of the Universal Registration Document including the Annual Financial r…
|
English | PDF • 100.4 KB | ||
| 2024-03-28 10:50 |
Communiqué de mise à disposition du Document d'Enregistrement Universel incluan…
|
French | PDF • 103.0 KB | ||
| 2024-03-27 18:01 |
bioMérieux receives Dual 510(k) clearance and CLIA-waiver approval for the BIOF…
|
English | PDF • 228.2 KB | ||
| 2024-03-27 18:01 |
bioMérieux obtient l'agrément 510(k) et la dérogation CLIA pour le panel BIOFIR…
|
French | PDF • 231.6 KB | ||
| 2024-03-27 11:01 |
Document d'enregistrement universel 2023
|
French | ZIP • 38.0 MB | ||
| 2024-03-27 11:01 |
Document d'enregistrement universel 2023
|
French | ZIP • 38.0 MB | ||
| 2024-03-25 17:30 |
AG 2024 - Avis de mise à disposition des documents préparatoires
|
French | PDF • 104.5 KB |
Automate Your Workflow. Get a real-time feed of all bioMérieux filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for bioMérieux
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for bioMérieux via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-09-04 | N/A | Other | Sell | 1,432 | 137,517.82 EUR |
| 2023-09-04 | N/A | Other | Sell | 1,253 | 120,328.10 EUR |
| 2023-09-01 | N/A | Other | Other | 2,900 | N/A |
| 2023-06-23 | N/A | Other | Other | 323 | 24,971.13 EUR |
| 2023-06-23 | N/A | Other | Buy | 323 | 24,971.13 EUR |
| 2023-06-23 | N/A | Other | Buy | 300 | 23,193.00 EUR |
| 2023-06-23 | N/A | Other | Buy | 25 | 1,932.75 EUR |
| 2023-03-23 | N/A | Other | Sell | 16,500 | 1,650,415.80 EUR |
Peer Companies
